Caris Life Sciences, Inc. (CAI) › Cash & EquivalentsCaris Life Sciences, Inc. (CAI) — Cash & EquivalentsAnnual figures by fiscal year, from SEC filings.2024: $63.95M2025: $796.27M$796.27M2024Cash & Equivalents (USD)2025Fiscal YearCash & EquivalentsChange YoY2025$796.27M+1145.2%2024$63.95M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share